Minimum age of 11 set for UK puberty blocker trial
AI Summary
The UK is initiating a clinical trial for puberty-blocking drugs, setting a minimum age of 11 for participants. This decision comes amid ongoing debates about gender identity treatment for minors. By limiting the trial to children aged 11 and above, the authorities aim to ensure that only those who are sufficiently mature understand the long-term implications of the treatment. This move underscores the need for careful, age-appropriate medical interventions in the realm of gender health.
Original Source
Read the full article at Bbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.